Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle protein 20 homolog (CDC20) is an essential regulator of cell division, primarily functioning to activate the anaphase promoting complex/cyclosome (APC/C). This activation leads to the degradation of securin and S/M-phase cyclins, enabling sister chromatid separation and mitotic exit. CDC20 plays a crucial role in microtubule-dependent processes like nuclear movement and chromosome separation. Overexpression of CDC20 has been implicated in various cancers, promoting cell proliferation, inhibiting apoptosis, and enhancing cell migration and invasion. It is considered a promising therapeutic target, and several medicines that inhibit CDC20 have been developed.
Inhibition of CDC20 function, leading to cell cycle arrest and apoptosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle protein 20 homolog (CDC20).